A food-derived supplement extends life and healthspan in aged mice
Clearing the cellular clutter
Researchers at the University of Chicago discovered that vanadyl sulfate, a molecule found in foods like oats and tea, kills senescent cells and extends lifespan in male mice. The study demonstrates that late-life treatment significantly improves healthspan.
Health news
Exercise and Mood: Italian Study Links Physical Activity to Lower Depression Symptoms
Screen Time in Childhood Linked to Unexpected Cognitive Boost in Teens, 8‑Year Study Shows
Workplace stress and anxiety are taking a heavy toll on employees, with one in three workers reporting that the strain is not easing
Daily Food Habit Tied to Lower Risk of Anxiety and DepressionThe research team identified cellular senescence as a key driver of aging. As bodies age, more cells enter a dormant, non-dividing state. These senescent cells accumulate and secrete inflammatory factors that damage surrounding healthy tissue. Vanadyl sulfate targets these cells specifically, clearing them from the system.
Does this translate to humans?
The compound works by inducing death in senescent cells without harming normal cells. This selective elimination reduces chronic inflammation and restores tissue function. Mice treated in late life showed measurable gains in both total lifespan and time spent healthy.
Researchers caution that mouse results do not guarantee human outcomes. Vanadyl sulfate is already sold as an over-the-counter supplement, but clinical trials in humans are needed to confirm efficacy and safety. The molecule's food-derived origin makes it a promising candidate for further study.
What is vanadyl sulfate? It is a vanadium-based compound naturally present in oats, tea, and certain seafood. It is marketed as a dietary supplement.
Frequently Asked Questions
How does it kill senescent cells? The compound triggers programmed cell death specifically in senescent cells, reducing their harmful secretions and restoring tissue health.
Can humans take it now? It is available over the counter, but human clinical evidence is still limited. Researchers recommend waiting for trial results before widespread use.